FDA Prohibits Sales of Dietary Supplements Containing Ephedra

On February 9, 2004, the Food and Drug Administration (FDA) issued a final rule prohibiting the sale of dietary supplements containing ephedrine alkaloids (ephedra) because such supplements present an unreasonable risk of illness or injury. The rule will become effective in 60 days. In addition, FDA reiterates its advice that consumers stop using ephedra products immediately.

Fact Sheet

JAMA Ephedra Publications (3/10/03)

Other Resources